pim 2 inhibitor smi 16a (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
94
Structured Review
MedChemExpress
pim 2 inhibitor smi 16a
Pim 2 Inhibitor Smi 16a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pim+2+inhibitor+smi+16a/SMI-16a/pm40557764-231-74-86
Average 94 stars, based on 9 article reviews
Pim 2 Inhibitor Smi 16a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pim+2+inhibitor+smi+16a/SMI-16a/pm40557764-231-74-86
Average 94 stars, based on 9 article reviews
pim 2 inhibitor smi 16a - by Bioz Stars,
2026-10
94/100 stars
Images
Related Articles
Cell Culture:Article Title: Combining PIM-2 and PARP1 Inhibitors Induces MICA Expression on Multiple Myeloma Cells to Activate NK Cells through NKG2D Binding. Article Snippet: .. NK-92 cells were cultured in a specialized NK-92 medium, strictly following the operational guidelines provided by Wuhan Puno Life Technology Co., Ltd. Primary human NK cells from the peripheral blood of MM patients were expanded ex vivo using feeder-free cytokine cocktails (e.g., IL-15 (50 ng mL−1) + IL-21 (20 ng mL−1) + ALT-803 (IL-15 superagonist, 10 nM)), achieving greater than 40-fold proliferation over 14 days while maintaining a purity of CD56+CD3- cells exceeding 90%.The Article Title: Combining PIM‐2 and PARP1 Inhibitors Induces MICA Expression on Multiple Myeloma Cells to Activate NK Cells through NKG2D Binding Article Snippet: .. NK‐92 cells were cultured in a specialized NK‐92 medium, strictly following the operational guidelines provided by Wuhan Puno Life Technology Co., Ltd. Primary human NK cells from the peripheral blood of MM patients were expanded ex vivo using feeder‐free cytokine cocktails (e.g., IL‐15 (50 ng mL −1 ) + IL‐21 (20 ng mL −1 ) + ALT‐803 (IL‐15 superagonist, 10 nM)), achieving greater than 40‐fold proliferation over 14 days while maintaining a purity of CD56+CD3‐ cells exceeding 90%.The Ex Vivo:Article Title: Combining PIM-2 and PARP1 Inhibitors Induces MICA Expression on Multiple Myeloma Cells to Activate NK Cells through NKG2D Binding. Article Snippet: .. NK-92 cells were cultured in a specialized NK-92 medium, strictly following the operational guidelines provided by Wuhan Puno Life Technology Co., Ltd. Primary human NK cells from the peripheral blood of MM patients were expanded ex vivo using feeder-free cytokine cocktails (e.g., IL-15 (50 ng mL−1) + IL-21 (20 ng mL−1) + ALT-803 (IL-15 superagonist, 10 nM)), achieving greater than 40-fold proliferation over 14 days while maintaining a purity of CD56+CD3- cells exceeding 90%.The Article Title: Combining PIM‐2 and PARP1 Inhibitors Induces MICA Expression on Multiple Myeloma Cells to Activate NK Cells through NKG2D Binding Article Snippet: .. NK‐92 cells were cultured in a specialized NK‐92 medium, strictly following the operational guidelines provided by Wuhan Puno Life Technology Co., Ltd. Primary human NK cells from the peripheral blood of MM patients were expanded ex vivo using feeder‐free cytokine cocktails (e.g., IL‐15 (50 ng mL −1 ) + IL‐21 (20 ng mL −1 ) + ALT‐803 (IL‐15 superagonist, 10 nM)), achieving greater than 40‐fold proliferation over 14 days while maintaining a purity of CD56+CD3‐ cells exceeding 90%.The |